leisure time -WSS

leisure time

author：comprehensive 2025-09-29 19:05:00 - browse：9439

JOSEPH PREZIOSO/AFP via Getty Images

LONDON — The U.K.’s cost-effectiveness watchdog said Thursday it is not yet recommending Vertex’s CRISPR-based therapy for sickle cell disease, saying in draft guidance it has questions about the medicine’s lasting benefits for patients.

U.K. regulators approved the therapy, known as Casgevy or exa-cel, last year, granting it the world’s first authorization for any CRISPR-based medicine. But observers have been watching to see how the U.K.’s National Institute for Health and Care Excellence, as well as similar agencies in European countries, would view the pricey, one-time therapy. NICE needs to recommend the therapy for it to be offered in the National Health Service.

In the U.S., Casgevy has a list price of $2.2 million. It was developed by Vertex in partnership with CRISPR Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： How artificial intelligence is being used to detect, treat cancer

Wikipedia

WSS

Stanford president's case begs question: Who takes blame?

FDA official pushes for dedicated emerging pathogens team

CDC backtracks, saying fully vaccinated people can go maskless indoors

Review: 'Barbie' will hit you like a shot in the heart

I learned firsthand about improving diversity in clinical trials

Indian pharmaceutical industry in denial over drug

focus

leisure time

leisure time

Medicare details structure of new drug price negotiation program

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Elizabeth Warren probes abortion access

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Driven by the pandemic, applicants flood public health schools

In Memoriam: Notable people who died in 2023

HIPAA doesn't protect reproductive records from prosecutors

focus

Ending racial health disparities hinges on penalties, political will

What to know about Saharan dust affecting the US and how it can affect health

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

In new study, freeze

7 of the most gruesome medical devices in history

Organ transplantation is at a crossroads. Major reform is needed

Wikipedia

entertainment

entertainment

entertainment